Legal status CA: Schedule II PubChem CID 11559386 3D model (Jmol) Interactive image ChemSpider ID 9734160 | CAS Number 895155-78-9 Formula C20H24F3NO Molar mass 351.405 g/mol | |
![]() | ||
XLR-12 is an indole-based synthetic cannabinoid drug that was invented by Abbott Laboratories in 2006. It is an analogue of XLR-11 where the 5-fluoropentyl chain has been replaced with a 4,4,4-trifluorobutyl chain. XLR-12 is relatively highly selective for the CB2 receptor, with a Ki of 0.09 nM and 167x selectivity over the related CB1 receptor, however it still retains appreciable affinity for CB1 with a Ki of 15 nM.
Legal status
XLR-12 is illegal in Hungary and Japan.
References
XLR-12 Wikipedia(Text) CC BY-SA